SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-035592
Filing Date
2020-02-13
Accepted
2020-02-13 16:18:27
Documents
1
Group Members
FLAGSHIP VENTURES FUND V GENERAL PARTNERS LLCNOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d835870dsc13ga.htm SC 13G/A 69755
  Complete submission text file 0001193125-20-035592.txt   71362
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Subject) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90223 | Film No.: 20610809
SIC: 2836 Biological Products, (No Diagnostic Substances)